Crossmark

Acquired T790M-positive Squamous Cell Lung Carcinoma that Responded to Osimertinib

Crossref DOI link: https://doi.org/10.1016/j.arbres.2019.04.004

Published Print: 2019-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Yamasaki, Masahiro

Funaishi, Kunihiko

Daido, Wakako

Hattori, Noboru
License Information

Text and Data Mining valid from 2019-11-01
More Information

This article is maintained by: Elsevier

Article Title: Acquired T790M-positive Squamous Cell Lung Carcinoma that Responded to Osimertinib

Journal Title: Archivos de Bronconeumología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.arbres.2019.04.004

Content Type: simple-article

Copyright: © 2019 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.